{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:02:21Z","timestamp":1787238141983,"version":"build-2736575974"},"reference-count":104,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T00:00:00Z","timestamp":1398211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s40620-014-0092-x","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T05:19:16Z","timestamp":1398143956000},"page":"607-617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Osteoprotegerin and kidney disease"],"prefix":"10.1093","volume":"27","author":[{"given":"Alejandra","family":"Monta\u00f1ez-Barrag\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaias","family":"G\u00f3mez-Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria D.","family":"Sanchez-Ni\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro C.","family":"Ucero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Gonz\u00e1lez-Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,4,23]]},"reference":[{"issue":"9888","key":"92_CR1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K et al (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382(9888):260","journal-title":"Lancet"},{"issue":"9889","key":"92_CR2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","volume":"382","author":"RT Gansevoort","year":"2013","unstructured":"Gansevoort RT, Correa-Rotter R, Hemmelgarn BR et al (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382(9889):339","journal-title":"Lancet"},{"issue":"16","key":"92_CR3","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.2009.1488","volume":"302","author":"DJ Jager de","year":"2009","unstructured":"de Jager DJ, Grootendorst DC, Jager KJ et al (2009) Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 302(16):1782","journal-title":"JAMA"},{"key":"92_CR4","first-page":"S1","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD\u2013MBD). Kidney Int Suppl 113:S1","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"92_CR5","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.carpath.2012.02.008","volume":"21","author":"E Gonzalez-Parra","year":"2012","unstructured":"Gonzalez-Parra E, Tu\u00f1\u00f3n J, Egido J, Ortiz A (2012) Phosphate: a stealthier killer than previously thought? Cardiovasc Pathol 21(5):372","journal-title":"Cardiovasc Pathol"},{"issue":"9900","key":"92_CR6","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","volume":"382","author":"SA Jamal","year":"2013","unstructured":"Jamal SA, Vandermeer B, Raggi P et al (2013) Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 382(9900):1268","journal-title":"Lancet"},{"issue":"9900","key":"92_CR7","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(13)61165-4","volume":"382","author":"A Ortiz","year":"2013","unstructured":"Ortiz A, Sanchez-Ni\u00f1o MD (2013) The demise of calcium-based phosphate binders. Lancet 382(9900):1232","journal-title":"Lancet"},{"issue":"Suppl 4","key":"92_CR8","doi-asserted-by":"crossref","first-page":"iv6","DOI":"10.1093\/ndt\/gfs426","volume":"27","author":"MC Izquierdo","year":"2012","unstructured":"Izquierdo MC, Perez-Gomez MV, Sanchez-Ni\u00f1o MD et al (2012) Klotho, phosphate and inflammation\/ageing in chronic kidney disease. Nephrol Dial Transplant 27(Suppl 4):iv6","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"92_CR9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","volume":"22","author":"MC Hu","year":"2011","unstructured":"Hu MC, Shi M, Zhang J et al (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22(1):124","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"92_CR10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00246-010-9711-z","volume":"31","author":"M Salamat","year":"2010","unstructured":"Salamat M, Dhar PK, Neagu DL, Lyon JB (2010) Aortic calcification in a patient with Hutchinson\u2013Gilford progeria syndrome. Pediatr Cardiol 31(6):925","journal-title":"Pediatr Cardiol"},{"issue":"4","key":"92_CR11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MNH.0b013e328362155b","volume":"22","author":"ZA Massy","year":"2013","unstructured":"Massy ZA, Dr\u00fceke TB (2013) Vascular calcification. Curr Opin Nephrol Hypertens 22(4):405","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"92_CR12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1681\/ASN.2011121191","volume":"24","author":"R Shroff","year":"2013","unstructured":"Shroff R, Long DA, Shanahan C (2013) Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol 24(2):179","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"92_CR13","first-page":"389","volume":"33","author":"ALM Francisco de","year":"2013","unstructured":"de Francisco ALM, Rodr\u00edguez M (2013) Magnesium\u2014its role in CKD. Nefrologia 33(3):389","journal-title":"Nefrologia"},{"issue":"4","key":"92_CR14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5312\/wjo.v4.i4.186","volume":"4","author":"TJ Martin","year":"2013","unstructured":"Martin TJ (2013) Historically significant events in the discovery of RANK\/RANKL\/OPG. World J Orthop 4(4):186","journal-title":"World J Orthop"},{"key":"92_CR15","doi-asserted-by":"crossref","unstructured":"Gallagher JC, Tella SH (2013) Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol. doi: 10.1016\/j.jsbmb.2013.09.008","DOI":"10.1016\/j.jsbmb.2013.09.008"},{"issue":"9","key":"92_CR16","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","volume":"12","author":"N Bucay","year":"1998","unstructured":"Bucay N, Sarosi I, Dunstan CR et al (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12(9):1260","journal-title":"Genes Dev"},{"issue":"9","key":"92_CR17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","volume":"3","author":"BB Aggarwal","year":"2003","unstructured":"Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3(9):745","journal-title":"Nat Rev Immunol"},{"issue":"5996","key":"92_CR18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/312724a0","volume":"312","author":"D Pennica","year":"1984","unstructured":"Pennica D, Nedwin GE, Hayflick JS et al (1984) Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312(5996):724","journal-title":"Nature"},{"issue":"3","key":"92_CR19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0952-7915(94)90119-8","volume":"6","author":"RJ Armitage","year":"1994","unstructured":"Armitage RJ (1994) Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immunol 6(3):407","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"92_CR20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/stem.5530120501","volume":"12","author":"D Cosman","year":"1994","unstructured":"Cosman D (1994) A family of ligands for the TNF receptor superfamily. Stem Cells 12(5):440","journal-title":"Stem Cells"},{"issue":"1","key":"92_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jlb.60.1.1","volume":"60","author":"M Lotz","year":"1996","unstructured":"Lotz M, Setareh M, von Kempis J, Schwarz H (1996) The nerve growth factor\/tumor necrosis factor receptor family. J Leukoc Biol 60(1):1","journal-title":"J Leukoc Biol"},{"issue":"50","key":"92_CR22","doi-asserted-by":"crossref","first-page":"41155","DOI":"10.1074\/jbc.M506366200","volume":"280","author":"LA Schneeweis","year":"2005","unstructured":"Schneeweis LA, Willard D, Milla ME (2005) Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-kappaB ligand. J Biol Chem 280(50):41155","journal-title":"J Biol Chem"},{"issue":"6","key":"92_CR23","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1744-9987.2012.01097.x","volume":"16","author":"N Rashtchizadeh","year":"2012","unstructured":"Rashtchizadeh N, Ghorbanihaghjo A, Argani H et al (2012) Serum receptor activator of nuclear factor-\u03ba B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients. Ther Apher Dial 16(6):600","journal-title":"Ther Apher Dial"},{"issue":"4 Suppl 1","key":"92_CR24","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1053\/ajkd.2001.27437","volume":"38","author":"T Sato","year":"2001","unstructured":"Sato T, Tominaga Y, Iwasaki Y et al (2001) Osteoprotegerin levels before and after renal transplantation. Am J Kidney Dis 38(4 Suppl 1):S175","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"92_CR25","first-page":"209","volume":"36","author":"I Silva","year":"2011","unstructured":"Silva I, Branco JC (2011) Rank\/Rankl\/opg: literature review. Acta Reumatol Port 36(3):209","journal-title":"Acta Reumatol Port"},{"issue":"1","key":"92_CR26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2302\/kjm.58.29","volume":"58","author":"SK Tat","year":"2009","unstructured":"Tat SK, Pelletier JP, Velasco CR, Padrines M, Martel-Pelletier J (2009) New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target? Keio J Med 58(1):29","journal-title":"Keio J Med"},{"issue":"4","key":"92_CR27","first-page":"497","volume":"23","author":"AE Papadopouli","year":"2008","unstructured":"Papadopouli AE, Klonaris CN, Theocharis SE (2008) Role of OPG\/RANKL\/RANK axis on the vasculature. Histol Histopathol 23(4):497","journal-title":"Histol Histopathol"},{"issue":"1","key":"92_CR28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","volume":"15","author":"LC Hofbauer","year":"2000","unstructured":"Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15(1):2","journal-title":"J Bone Miner Res"},{"issue":"2","key":"92_CR29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2478\/v10042-009-0035-x","volume":"47","author":"K Klejna","year":"2009","unstructured":"Klejna K, Naumnik B, Gasowska K, My\u015bliwiec M (2009) OPG\/RANK\/RANKL signaling system and its significance in nephrology. Folia Histochem Cytobiol 47(2):199","journal-title":"Folia Histochem Cytobiol"},{"issue":"1","key":"92_CR30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12178-009-9046-7","volume":"2","author":"HL Wright","year":"2009","unstructured":"Wright HL, McCarthy HS, Middleton J, Marshall MJ (2009) RANK, RANKL and osteoprotegerin in bone biology and disease. Curr Rev Musculoskelet Med 2(1):56","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"2","key":"92_CR31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89(2):309","journal-title":"Cell"},{"issue":"7","key":"92_CR32","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2337\/dc12-2170","volume":"36","author":"D Gordin","year":"2013","unstructured":"Gordin D, Soro-Paavonen A, Thomas MC et al (2013) Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. Diabetes Care 36(7):1827","journal-title":"Diabetes Care"},{"issue":"43","key":"92_CR33","doi-asserted-by":"crossref","first-page":"31601","DOI":"10.1074\/jbc.M706078200","volume":"282","author":"S Vitovski","year":"2007","unstructured":"Vitovski S, Phillips JS, Sayers J, Croucher PI (2007) Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways. J Biol Chem 282(43):31601","journal-title":"J Biol Chem"},{"issue":"2","key":"92_CR34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1158\/0008-5472.CAN-08-2648","volume":"69","author":"F Lamoureux","year":"2009","unstructured":"Lamoureux F, Picarda G, Garrigue-Antar L et al (2009) Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma. Cancer Res 69(2):526","journal-title":"Cancer Res"},{"issue":"11","key":"92_CR35","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.str.2012.08.030","volume":"20","author":"CA Nelson","year":"2012","unstructured":"Nelson CA, Warren JT, Wang MW, Teitelbaum SL, Fremont DH (2012) RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor. Structure\u00a020(11):1971","journal-title":"Structure"},{"issue":"Suppl 1","key":"92_CR36","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2165","volume":"9","author":"BF Boyce","year":"2007","unstructured":"Boyce BF, Xing L (2007) Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 9(Suppl 1):S1","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"92_CR37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L (2008) Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch Biochem Biophys 473(2):139","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"92_CR38","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1182\/blood-2006-07-037994","volume":"109","author":"Y Li","year":"2007","unstructured":"Li Y, Toraldo G, Li A et al (2007) B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 109(9):3839","journal-title":"Blood"},{"issue":"2","key":"92_CR39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1445-5994.2008.01732.x","volume":"39","author":"E Romas","year":"2009","unstructured":"Romas E (2009) Clinical applications of RANK-ligand inhibition. Intern Med J 39(2):110","journal-title":"Intern Med J"},{"issue":"23","key":"92_CR40","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","volume":"273","author":"JG Emery","year":"1998","unstructured":"Emery JG, McDonnell P, Burke MB et al (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 273(23):14363","journal-title":"J Biol Chem"},{"issue":"5","key":"92_CR41","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1681\/ASN.2007050581","volume":"19","author":"C Lorz","year":"2008","unstructured":"Lorz C, Benito-Mart\u00edn A, Boucherot A et al (2008) The death ligand TRAIL in diabetic nephropathy. J Am Soc Nephrol 19(5):904","journal-title":"J Am Soc Nephrol"},{"key":"92_CR42","doi-asserted-by":"crossref","unstructured":"Sanchez-Ni\u00f1o MD, Benito-Martin A, Gon\u00e7alves S et al (2010) TNF superfamily: a growing saga of kidney injury modulators. Mediat Inflamm 2010. doi: 10.1155\/2010\/182958","DOI":"10.1155\/2010\/182958"},{"key":"92_CR43","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.2741\/3485","volume":"14","author":"C Lorz","year":"2009","unstructured":"Lorz C, Benito A, Ucero AC, Santamar\u00eda B, Ortiz A (2009) Trail and kidney disease. Front Biosci (Landmark Ed) 14:3740","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"6","key":"92_CR44","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1091\/mbc.E04-01-0059","volume":"15","author":"LB Pritzker","year":"2004","unstructured":"Pritzker LB, Scatena M, Giachelli CM (2004) The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival. Mol Biol Cell 15(6):2834","journal-title":"Mol Biol Cell"},{"issue":"2","key":"92_CR45","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1182\/blood-2007-01-068395","volume":"110","author":"G Zauli","year":"2007","unstructured":"Zauli G, Corallini F, Bossi F et al (2007) Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. Blood 110(2):536","journal-title":"Blood"},{"issue":"1","key":"92_CR46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0609.2010.01446.x","volume":"85","author":"M Kobayashi-Sakamoto","year":"2010","unstructured":"Kobayashi-Sakamoto M, Isogai E, Holen I (2010) Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells. Eur J Haematol 85(1):26","journal-title":"Eur J Haematol"},{"issue":"3","key":"92_CR47","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10456-013-9337-x","volume":"16","author":"Z Benslimane-Ahmim","year":"2013","unstructured":"Benslimane-Ahmim Z, Poirier F, Delomenie C et al (2013) Mechanistic study of the proangiogenic effect of osteoprotegerin. Angiogenesis 16(3):575","journal-title":"Angiogenesis"},{"issue":"1","key":"92_CR48","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2353\/ajpath.2008.070395","volume":"172","author":"A Lawrie","year":"2008","unstructured":"Lawrie A, Waterman E, Southwood M et al (2008) Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension. Am J Pathol 172(1):256","journal-title":"Am J Pathol"},{"issue":"9","key":"92_CR49","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1161\/01.ATV.0000236428.91125.e6","volume":"26","author":"BJ Bennett","year":"2006","unstructured":"Bennett BJ, Scatena M, Kirk EA et al (2006) Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE\u2212\/\u2212 mice. Arterioscler Thromb Vasc Biol 26(9):2117","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"92_CR50","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1084\/jem.188.5.997","volume":"188","author":"K Fuller","year":"1998","unstructured":"Fuller K, Wong B, Fox S, Choi Y, Chambers TJ (1998) TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 188(5):997","journal-title":"J Exp Med"},{"issue":"4","key":"92_CR51","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.192.4.463","volume":"192","author":"H Min","year":"2000","unstructured":"Min H, Morony S, Sarosi I et al (2000) Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 192(4):463","journal-title":"J Exp Med"},{"issue":"11","key":"92_CR52","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.RES.0000149165.99974.12","volume":"95","author":"P Collin-Osdoby","year":"2004","unstructured":"Collin-Osdoby P (2004) Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 95(11):1046","journal-title":"Circ Res"},{"key":"92_CR53","first-page":"125932","volume":"2013","author":"Y Wu","year":"2013","unstructured":"Wu Y, Liu J, Guo H et al (2013) Establishment of OPG transgenic mice and the effect of OPG on bone microarchitecture. Int J Endocrinol 2013:125932","journal-title":"Int J Endocrinol"},{"issue":"3","key":"92_CR54","first-page":"215","volume":"16","author":"E Malan","year":"1975","unstructured":"Malan E (1975) 23rd Congress of the European Society of Cardiovascular Surgery. J Cardiovasc Surg (Torino) 16(3):215","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"92_CR55","unstructured":"http:\/\/omim.org\/entry\/602643 . Accessed 1 Jan 2014"},{"issue":"6","key":"92_CR56","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.wneu.2010.01.022","volume":"73","author":"T Rehman","year":"2010","unstructured":"Rehman T, Ali R, Taylor C, Yonas H (2010) Bilateral giant cavernous carotid artery aneurysms in a child with juvenile Paget\u2019s disease. World Neurosurg 73(6):691","journal-title":"World Neurosurg"},{"issue":"1","key":"92_CR57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3174\/ajnr.A0755","volume":"29","author":"CA Allen","year":"2008","unstructured":"Allen CA, Hart BL, Taylor CL, Clericuzio CL (2008) Bilateral cavernous internal carotid aneurysms in a child with juvenile paget disease and osteoprotegerin deficiency. Am J Neuroradiol 29(1):7","journal-title":"Am J Neuroradiol"},{"issue":"4","key":"92_CR58","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jvs.2013.03.036","volume":"58","author":"A Saratzis","year":"2013","unstructured":"Saratzis A, Sarafidis P, Melas N, Saratzis N, Kitas G (2013) Impaired renal function is associated with mortality and morbidity after endovascular abdominal aortic aneurysm repair. J Vasc Surg 58(4):879","journal-title":"J Vasc Surg"},{"issue":"5","key":"92_CR59","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.jvs.2012.04.037","volume":"56","author":"VI Patel","year":"2012","unstructured":"Patel VI, Lancaster RT, Mukhopadhyay S et al (2012) Impact of chronic kidney disease on outcomes after abdominal aortic aneurysm repair. J Vasc Surg 56(5):1206","journal-title":"J Vasc Surg"},{"issue":"5","key":"92_CR60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd3705","volume":"11","author":"DL Lacey","year":"2012","unstructured":"Lacey DL, Boyle WJ, Simonet WS et al (2012) Bench to bedside: elucidation of the OPG\u2013RANK\u2013RANKL pathway and the development of denosumab. Nat Rev Drug Discov 11(5):401","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"92_CR61","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIRCULATIONAHA.108.765776","volume":"118","author":"P Secchiero","year":"2008","unstructured":"Secchiero P, Zauli G (2008) Letter by Secchiero and Zauli regarding article, \u201costeoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(\u2212\/\u2212) mice\u201d. Circulation 118(2):e18 (author reply e19)","journal-title":"Circulation"},{"issue":"3","key":"92_CR62","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/CIRCULATIONAHA.107.707380","volume":"117","author":"S Morony","year":"2008","unstructured":"Morony S, Tintut Y, Zhang Z et al (2008) Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(\u2212\/\u2212) mice. Circulation 117(3):411","journal-title":"Circulation"},{"issue":"1","key":"92_CR63","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mce.2010.08.019","volume":"331","author":"B Toffoli","year":"2011","unstructured":"Toffoli B, Bernardi S, Candido R et al (2011) Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. Mol Cell Endocrinol 331(1):136","journal-title":"Mol Cell Endocrinol"},{"key":"92_CR64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2741\/2665","volume":"13","author":"F Corallini","year":"2008","unstructured":"Corallini F, Rimondi E, Secchiero P (2008) TRAIL and osteoprotegerin: a role in endothelial physiopathology? Front Biosci 13:135","journal-title":"Front Biosci"},{"issue":"1","key":"92_CR65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2011.05.019","volume":"218","author":"B Toffoli","year":"2011","unstructured":"Toffoli B, Pickering RJ, Tsorotes D et al (2011) Osteoprotegerin promotes vascular fibrosis via a TGF-\u03b21 autocrine loop. Atherosclerosis 218(1):61","journal-title":"Atherosclerosis"},{"issue":"10","key":"92_CR66","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/hq1001.097102","volume":"21","author":"PA Price","year":"2001","unstructured":"Price PA, June HH, Buckley JR, Williamson MK (2001) Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21(10):1610","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"92_CR67","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/ndt\/gfr658","volume":"27","author":"M Hayashi","year":"2012","unstructured":"Hayashi M, Takamatsu I, Kanno Y et al (2012) A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol Dial Transplant 27(4):1580","journal-title":"Nephrol Dial Transplant"},{"issue":"3 Suppl","key":"92_CR68","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cncr.11138","volume":"97","author":"JJ Body","year":"2003","unstructured":"Body JJ, Greipp P, Coleman RE et al (2003) A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Cancer 97(3 Suppl):887","journal-title":"Cancer"},{"issue":"Suppl 1","key":"92_CR69","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/ar2171","volume":"9","author":"EM Schwarz","year":"2007","unstructured":"Schwarz EM, Ritchlin CT (2007) Clinical development of anti-RANKL therapy. Arthritis Res Ther 9(Suppl 1):S7","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"92_CR70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/2230-8210.83401","volume":"15","author":"SS Kohli","year":"2011","unstructured":"Kohli SS, Kohli VS (2011) Role of RANKL-RANK\/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications. Indian J Endocrinol Metab 15(3):175","journal-title":"Indian J Endocrinol Metab"},{"key":"92_CR71","unstructured":"http:\/\/www.ema.europa.eu\/ . Accessed 1 Jan 2014"},{"key":"92_CR72","unstructured":"http:\/\/clinicaltrials.gov\/ . Accessed 1 Jan 2014"},{"issue":"3","key":"92_CR73","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrneph.2011.170","volume":"8","author":"A Ortiz","year":"2012","unstructured":"Ortiz A, Massy ZA, Fliser D et al (2012) Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis. Nat Rev Nephrol 8(3):141","journal-title":"Nat Rev Nephrol"},{"issue":"18","key":"92_CR74","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","volume":"109","author":"S Kiechl","year":"2004","unstructured":"Kiechl S, Schett G, Wenning G et al (2004) Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 109(18):2175","journal-title":"Circulation"},{"issue":"6","key":"92_CR75","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1291\/hypres.31.1163","volume":"31","author":"S Mikami","year":"2008","unstructured":"Mikami S, Hamano T, Fujii N et al (2008) Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients. Hypertens Res 31(6):1163","journal-title":"Hypertens Res"},{"issue":"6","key":"92_CR76","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1440-1797.2011.01481.x","volume":"16","author":"JQ Jiang","year":"2011","unstructured":"Jiang JQ, Lin S, Xu PC, Zheng ZF, Jia JY (2011) Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease\u2013mineral and bone disorder. Nephrology (Carlton) 16(6):588","journal-title":"Nephrology (Carlton)"},{"issue":"11","key":"92_CR77","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/ndt\/gfp301","volume":"24","author":"M Morena","year":"2009","unstructured":"Morena M, Dupuy AM, Jaussent I et al (2009) A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. Nephrol Dial Transplant 24(11):3389","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"92_CR78","doi-asserted-by":"crossref","first-page":"e36175","DOI":"10.1371\/journal.pone.0036175","volume":"7","author":"M Morena","year":"2012","unstructured":"Morena M, Jaussent I, Halkovich A et al (2012) Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients. PLoS One 7(5):e36175","journal-title":"PLoS One"},{"issue":"11","key":"92_CR79","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.2215\/CJN.03910411","volume":"6","author":"JJ Scialla","year":"2011","unstructured":"Scialla JJ, Leonard MB, Townsend RR et al (2011) Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. Clin J Am Soc Nephrol 6(11):2612","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"92_CR80","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1093\/ndt\/gfp253","volume":"24","author":"MK Sigrist","year":"2009","unstructured":"Sigrist MK, Levin A, Er L, McIntyre CW (2009) Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification. Nephrol Dial Transplant 24(10):3157","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"92_CR81","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ndt\/gfr316","volume":"27","author":"ML Ford","year":"2012","unstructured":"Ford ML, Smith ER, Tomlinson LA, Chatterjee PK, Rajkumar C, Holt SG (2012) FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease\u2013mineral bone disorder and the heart. Nephrol Dial Transplant 27(2):727","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"92_CR82","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","volume":"23","author":"F Duranton","year":"2012","unstructured":"Duranton F, Cohen G, De Smet R et al (2012) Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 23(7):1258","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"92_CR83","first-page":"955","volume":"22","author":"GB Mohamed","year":"2011","unstructured":"Mohamed GB, Abdel-Latif EA (2011) Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome. Saudi J Kidney Dis Transplant 22(5):955","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"92_CR84","doi-asserted-by":"crossref","unstructured":"Liabeuf S, Okazaki H, Desjardins L et al (2013) Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario? Nephrol Dial Transplant [Epub ahead of print]","DOI":"10.1093\/ndt\/gft368"},{"issue":"5","key":"92_CR85","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2362.2011.02619.x","volume":"42","author":"AM Bl\u00e1zquez-Medela","year":"2012","unstructured":"Bl\u00e1zquez-Medela AM, Garc\u00eda-Ortiz L, G\u00f3mez-Marcos MA et al (2012) Osteoprotegerin is associated with cardiovascular risk in hypertension and\/or diabetes. Eur J Clin Invest 42(5):548","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"92_CR86","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.2337\/dc06-0631","volume":"29","author":"JY Shin","year":"2006","unstructured":"Shin JY, Shin YG, Chung CH (2006) Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes. Diabetes Care 29(7):1664","journal-title":"Diabetes Care"},{"issue":"2","key":"92_CR87","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ndt\/17.2.233","volume":"17","author":"G Coen","year":"2002","unstructured":"Coen G, Ballanti P, Balducci A et al (2002) Serum osteoprotegerin and renal osteodystrophy. Nephrol Dial Transplant 17(2):233","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"92_CR88","doi-asserted-by":"crossref","first-page":"149","DOI":"10.20452\/pamw.1678","volume":"123","author":"K Janda","year":"2013","unstructured":"Janda K, Krzanowski M, Chowaniec E et al (2013) Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. Pol Arch Med Wewn 123(4):149","journal-title":"Pol Arch Med Wewn"},{"issue":"3","key":"92_CR89","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejvs.2011.12.026","volume":"43","author":"FA Lederle","year":"2012","unstructured":"Lederle FA (2012) The strange relationship between diabetes and abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 43(3):254","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"92_CR90","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/eje.1.02049","volume":"154","author":"LM Rasmussen","year":"2006","unstructured":"Rasmussen LM, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A (2006) Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients. Eur J Endocrinol 154(1):75","journal-title":"Eur J Endocrinol"},{"key":"92_CR91","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2369-14-10","volume":"14","author":"P Pencak","year":"2013","unstructured":"Pencak P, Czerwie\u0144ska B, Ficek R et al (2013) Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients. BMC Nephrol 14:10","journal-title":"BMC Nephrol"},{"issue":"11","key":"92_CR92","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1111\/j.1600-6143.2009.02814.x","volume":"9","author":"AS Bargnoux","year":"2009","unstructured":"Bargnoux AS, Dupuy AM, Garrigue V et al (2009) Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels. Am J Transplant 9(11):2571","journal-title":"Am J Transplant"},{"issue":"6","key":"92_CR93","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1681\/ASN.2005121368","volume":"17","author":"J Hjelmesaeth","year":"2006","unstructured":"Hjelmesaeth J, Ueland T, Flyvbjerg A et al (2006) Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients. J Am Soc Nephrol 17(6):1746","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"92_CR94","first-page":"774","volume":"22","author":"K Matsubara","year":"2009","unstructured":"Matsubara K, Stenvinkel P, Qureshi AR et al (2009) Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease. J Nephrol 22(6):774","journal-title":"J Nephrol"},{"issue":"6","key":"92_CR95","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1093\/ndt\/gfr694","volume":"27","author":"M Svensson","year":"2012","unstructured":"Svensson M, Dahle DO, Mj\u00f8en G et al (2012) Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. Nephrol Dial Transplant 27(6):2571","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"92_CR96","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/TP.0b013e3182934cee","volume":"96","author":"M Meneghini","year":"2013","unstructured":"Meneghini M, Regalia A, Alfieri C et al (2013) Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation. Transplantation 96(1):42","journal-title":"Transplantation"},{"issue":"1","key":"92_CR97","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000357787","volume":"39","author":"JR Lewis","year":"2014","unstructured":"Lewis JR, Lim WH, Zhu K et al (2014) Elevated osteoprotegerin predicts declining renal function in elderly women: a 10-year prospective cohort study. Am J Nephrol 39(1):66","journal-title":"Am J Nephrol"},{"issue":"7","key":"92_CR98","doi-asserted-by":"crossref","first-page":"e68987","DOI":"10.1371\/journal.pone.0068987","volume":"8","author":"S Zhou","year":"2013","unstructured":"Zhou S, Fang X, Xin H, Li W, Qiu H, Guan S (2013) Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-J\u03ba\/Msx2 signaling pathway. PLoS One 8(7):e68987","journal-title":"PLoS One"},{"issue":"4","key":"92_CR99","first-page":"219","volume":"103","author":"B Fern\u00e1ndez Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez Fern\u00e1ndez B, Elewa U, S\u00e1nchez-Ni\u00f1o MD et al (2012) 2012 Update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials. Minerva Med 103(4):219","journal-title":"Minerva Med"},{"issue":"3","key":"92_CR100","first-page":"353","volume":"29","author":"S Szteyn","year":"1988","unstructured":"Szteyn S (1988) Types of neurons in nucleus olivaris inferior of the European bison. J Hirnforsch 29(3):353","journal-title":"J Hirnforsch"},{"issue":"8","key":"92_CR101","doi-asserted-by":"crossref","first-page":"e72387","DOI":"10.1371\/journal.pone.0072387","volume":"8","author":"A Benito-Martin","year":"2013","unstructured":"Benito-Martin A, Ucero AC, Zubiri I et al (2013) Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine. PLoS One 8(8):e72387","journal-title":"PLoS One"},{"issue":"10","key":"92_CR102","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3899\/jrheum.081112","volume":"36","author":"AN Kiani","year":"2009","unstructured":"Kiani AN, Johnson K, Chen C et al (2009) Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. J Rheumatol 36(10):2224","journal-title":"J Rheumatol"},{"key":"92_CR103","doi-asserted-by":"crossref","unstructured":"West SL, Lok CE, Jamal SA (2013) Osteoprotegerin and fractures in men and women with chronic kidney disease. J Bone Miner Metab. doi: 10.1007\/s00774-013-0506-1","DOI":"10.1007\/s00774-013-0506-1"},{"issue":"1","key":"92_CR104","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4049\/jimmunol.1103387","volume":"189","author":"X Luan","year":"2012","unstructured":"Luan X, Lu Q, Jiang Y et al (2012) Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin. J Immunol 189(1):245","journal-title":"J Immunol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0092-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-014-0092-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0092-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:59Z","timestamp":1777564679000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/27\/6\/607\/8372239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,23]]},"references-count":104,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["92"],"URL":"https:\/\/doi.org\/10.1007\/s40620-014-0092-x","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,23]]}}}